Mechanistic Distinctions Between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy With Gemcitabine
Cancer Research - United States
doi 10.1158/0008-5472.can-17-3932
Full Text
Open PDFAbstract
Available in full text
Date
May 7, 2018
Authors
Publisher
American Association for Cancer Research (AACR)